Date/TimeDate(s) - September 23, 2021
10:00 AM - 11:00 AM CT
Pathology assessments provide crucial insights into how the body reacts to implanted materials, devices and substances by examining the tissue response and/or performance of a device or its materials. This information delivers critical data for evaluating patient safety of a device and in some cases, can be used to evaluate efficacy.
Understanding the basics of a pathology assessment, including how a sample is processed, which stains are most relevant for evaluating specified endpoints, and how a Pathologist scores samples are important components of any preclinical study. Just as important are the data derived from the pathological assessment and how this information is utilized to demonstrate device safety in regulatory body submissions and insight into how a device performs clinically.
Join us for this upcoming webinar as our experts discuss:
- How pathology is used to assess medical devices
- Pathology techniques, including gross pathology, histology and microscopic pathology
- Potential pathology limitations such as data extrapolation, endpoint selection and study design
- How manufacturers can properly understand pathology results, which leads to a better recognition of how a device is evaluated for safety and/or performance
Muhammad AhsanPrincipal Toxicologic Pathologist
Muhammad holds a Doctorate of Veterinary Medicine (DVM) as well as a Masters in Veterinary Pathology from the University of Agriculture, Faisalabad and a PhD from Tulane Uninveristy School of Medicine. Dr. Ahsan is a Diplomate of the American College of Veterinary Pathologists (ACVP) in Anatomic Pathology as well as a Diplomate of the American Board of Toxicology (ABT). He has over 20 years of experience in research with 5+ years in medical device pathology. Dr. Ahsan has been with APS since 2016.